Chief Operational Officer and Pharma Executive
Tariq is an executive leader in biotech, pharmaceutical, clinical research organization, and clinical research sites. Tariq also serves as Chief Operational Officer at Gene Therapy and Immunotherapy-oncology platform biotech (Theragene Pharma).
Startup and Expansion Investment Executive
An accomplished C-level senior executive. Specializes in M&A transactions, emerging enterprises, revenue generation, turnaround situations, investment funding, strategic planning and management team development. Veteran of the wireless, telecommunications, and automotive industry. Past capital raises include Car Offer, CLiCs, BYNA, Rio Genesis, etc.
Dr. Michael Morelock
Dr. Michael Morelock has been a Fellow of the American Academy of Otolaryngology, Head and Neck Surgery since 1984. He has experience in a wide variety of medical settings from solo to a large multispecialty HMO, has participated in humanitarian medical missions to third world and developing countries, and has been a Principal Investigator in several clinical research trials. He has previously been a medical advisor for a software company involved in chronic care management, remote patient monitoring, and clinical research.
Medhera, a division of Hifinite Inc., offers a full-stack medication adherence solution to help improve medication adherence rates.
Based in San Diego, CA, Medhera delivers leading edge healthcare technology of the future, today. Medhera assists with data management and mitigating risk, while saving time, money, and lives!
Chief Executive Officer
Mohammed is an entrepreneur and an accomplished executive with extensive experience in leadership, strategy, operations, product development, sales, and marketing. He is a product visionary with a knack for developing products that solve real market needs. He is a highly skilled and educated professional with a Master of Science in Engineering from Clemson University and a master’s degree in management from Harvard University.
Ashraf is a data and technology architect with experiences in iOT, cloud, and big data technologies. He has over 19 years of experience in leading software projects. Ashraf is savvy in various front-end and back-end technologies, databases, algorithms, and mobile application development.
He has a Master of Science in Computer Science from San Diego State University and a master’s degree in management from Harvard University.
Chief Technology Officer
Chief Information Officer
Sarfraz is a guru in end-to-end product development and has over 20 years of experience in the development of technology solutions. Sarfraz is a former senior engineering manager at L-3 Communications, where he held numerous positions and directed multiple comprehensive engineering projects.
Dr. Dane Shipp
Dr. Dane Shipp, Medical Director at SyneosHealth, is an obstetrician-gynecologist in Del Mar, California.
He is affiliated with multiple hospitals in the southern California area.
He has over 20 years of medical practice and is experienced in various healthcare delivery models. Dr. Shipp is also an independent entrepreneur, principal investigator in over 250 studies, and CEO and founder of a medical device company.
Dr. Anton Mityagin
Security Architect and Strategist
Dr. Anton Mityagin is an internet security leader with over 10 years of experience in computer security, software engineering, and data science.
He holds a Ph.D. in Computer Science from the University of California, San Diego. He is also an angel and real estate investor. Prior to Hifinite, Dr. Mityagin was a founding member of the security team at Dropbox where he served as an advisor to companies on building security, assessing risks, and solving fraud.
Chief Investment Officer
Ty Humes is a paradigm pioneer. He is adept at creating, growing, and managing business models into high margin revenue streams. He is an expert at restructuring and preparing companies for capital raise, and leading capital raise deals.
Between the US and China, Ty has led the management of all of sales, marketing, corporate development, public relations, and investment banking activities. He has managed the staff for both the public and private company divisions of Theragene Pharmaceuticals and its oncology initiatives.